Gilead taps former Roche exec to lead Kite unit
Sundry Photography         
Gilead Sciences (NASDAQ:GILD) has chosen Cindy Perettie, a former Roche (OTCQX:RHHBY) executive, to become EVP of its Kite unit. She will begin May 30.
At Roche (OTCPK:RHHVF), Perettie headed up the company's molecular lab solutions business. Earlier, she was head of global oncology strategy at the Swiss pharma's oncology unit.

Perettie replacesÂ Christi Shaw, who left Kite as CEO at the end of Q1.
Kite is focused on developing cell therapies that utilize the body's immune system to fight cancer.